Chemosensors,
Год журнала:
2025,
Номер
13(1), С. 14 - 14
Опубликована: Янв. 11, 2025
A
cationic
Ru(II)
complex
Ru1
with
5-phenyl-2,2′-bipyridine
as
ligand
was
synthesized
and
fully
characterized.
exhibits
significant
aggregation-induced
phosphorescent
emission
(AIPE)
activity
in
THF/H2O.
The
AIPE
property
of
has
been
successfully
used
to
detect
picric
acid
(PA)
aqueous
media.
a
sensitive
luminescence
quenching
response
PA,
high
constant
(KSV
=
2.5
×
104
M−1)
low
limit
detection
(LOD
91
nM).
In
addition,
demonstrates
sensitivity
selectivity
for
detecting
PA
different
common
water
samples.
UV-vis
absorption
spectra
lifetime
show
an
obvious
change
after
the
addition
into
samples,
indicating
that
process
is
combination
dynamic
static
quenching.
density
functional
theory
calculations
indicate
mechanism
photo-induced
electron
transfer.
Inorganic Chemistry,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 7, 2025
A
series
of
dinuclear
Ir(III)
complexes
have
been
constructed
for
enhanced
photodynamic
and
photothermal
therapy
(PDT
PTT)
cisplatin-resistant
non-small-cell
lung
cancer.
They
enter
cells
via
caveolar
endocytosis,
target
mitochondria
but
not
nuclear,
generate
both
singlet
oxygen
superoxide
anion,
release
heat
when
exposed
to
infrared
(IR)
irradiation,
thus
inducing
reactive
species
(ROS)-associated
cell
disruption
thermal
ablation.
The
IR-generated
ROS
can
further
activate
caspases,
triggering
apoptosis.
Additionally,
the
deplete
intracellular
glutathione,
lead
lipid
peroxidation,
induce
ferroptosis.
selected
complex
Angewandte Chemie International Edition,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 13, 2025
Abstract
Photoactivatable
metal
complexes
offer
the
prospect
of
novel
drugs
with
low
side
effects
and
new
mechanisms
action
to
combat
resistance
current
therapy.
We
highlight
recent
progress
in
design
platinum,
ruthenium,
iridium,
gold
other
transition
complexes,
especially
for
applications
as
anticancer
anti‐infective
agents.
In
particular,
understanding
excited
state
chemistry
related
identification
bioactive
species
(excited
metallomics/pharmacophores)
is
important.
metallodrugs
are
classified
here
photocatalysts,
photorelease
agents
ligand‐activated
Their
activation
wavelengths,
cellular
action,
experimental
theoretical
metallomics
states
photoproducts
discussed
explore
strategies
investigation
photoactivatable
metallodrugs.
These
have
potential
clinical
Photodynamic
Therapy
(PDT),
Photoactivated
Chemotherapy
(PACT)
Photothermal
(PTT).
Angewandte Chemie International Edition,
Год журнала:
2024,
Номер
63(27)
Опубликована: Апрель 24, 2024
A
planar
conjugated
ligand
functionalized
with
bithiophene
and
its
Ru(II),
Os(II),
Ir(III)
complexes
have
been
constructed
as
single-molecule
platform
for
synergistic
photodynamic,
photothermal,
chemotherapy.
The
significant
two-photon
absorption
at
808
nm
remarkable
singlet
oxygen
superoxide
anion
production
in
aqueous
solution
cells
when
exposed
to
infrared
irradiation.
most
potent
Ru(II)
complex
Ru7
enters
tumor
via
the
rare
macropinocytosis,
locates
both
nuclei
mitochondria,
regulates
DNA-related
chemotherapeutic
mechanisms
intranuclearly
including
DNA
topoisomerase
RNA
polymerase
inhibition
their
effects
photoactivated
apoptosis,
ferroptosis
cleavage.
exhibits
high
efficacy
vivo
malignant
melanoma
cisplatin-resistant
non-small
cell
lung
cancer
tumors,
a
100
%
survival
rate
of
mice,
low
toxicity
normal
residual
rate.
Such
an
activatable
metal
may
contribute
new
generation
single-molecule-based
integrated
diagnosis
treatment
address
drug
resistance
clinical
practice
phototherapy
large,
deeply
located
solid
tumors.
Inorganic Chemistry,
Год журнала:
2024,
Номер
63(17), С. 7792 - 7798
Опубликована: Апрель 15, 2024
Metallodrug-based
photodynamic
therapy
(PDT)
agents
have
demonstrated
significant
superiority
against
cancers,
while
their
different
chirality-induced
biological
activities
remain
largely
unexplored.
In
this
work,
we
successfully
developed
a
pair
of
enantiopure
mononuclear
Ir(III)-based
TLD-1433
analogues,
Δ-Ir-3T
and
Λ-Ir-3T,
enantiomer-dependent
anticancer
behaviors
were
investigated.
Photophysical
measurements
revealed
that
they
display
high
photostability
chemical
stability,
strong
absorption
at
400
nm
with
molar
extinction
coefficients
(ε
=
5.03
×
104
M–1
cm–1),
good
1O2
relative
quantum
yields
(ΦΔ
≈
47%).
Δ-
Λ-Ir-3T
showed
potent
efficacy
MCF-7
cancer
cells,
photocytotoxicity
index
≤44
238.
This
impressive
result,
to
the
best
our
knowledge,
represents
highest
value
among
reported
PDT
agents.
Remarkably,
tended
be
more
than
when
tested
SK-MEL-28,
HepG2,
LO2
consistent
results
across
multiple
test
repetitions.
Journal of the American Chemical Society,
Год журнала:
2023,
Номер
145(27), С. 14766 - 14775
Опубликована: Июнь 27, 2023
Investigation
on
the
interactions
between
enantiomers
of
chiral
drugs
and
biomolecules
can
help
precisely
understand
their
biological
behaviors
in
vivo
provide
insights
into
design
new
drugs.
Herein,
we
designed
synthesized
a
pair
optically
pure,
cationic,
double-stranded
dinuclear
Ir(III)-metallohelices
(Λ2R4-H
Δ2S4-H),
dramatic
enantiomer-dependent
photodynamic
therapy
(PDT)
responses
were
thoroughly
studied
vitro
vivo.
Compared
to
mononuclear
enantiomeric
or
racemic
[Ir(ppy)2(dppz)][PF6]
(Λ-/Δ-Ir,
rac-Ir)
that
with
high
dark
toxicity
low
photocytotoxicity
index
(PI)
values,
both
pure
metallohelices
displayed
negligible
while
exhibiting
very
distinctive
light
upon
irradiation.
The
PI
value
Λ2R4-H
was
approximately
428,
however,
Δ2S4-H
significantly
reached
63,966.
Interestingly,
only
found
migrate
from
mitochondria
nucleus
after
Further
proteomic
analysis
verified
activated
ATP-dependent
migration
process
irradiation,
subsequently
inhibited
activities
nuclear
proteins
such
as
superoxide
dismutase
1
(SOD1)
eukaryotic
translation
initiation
factor
5A
(EIF5A)
trigger
accumulation
anions
downregulate
mRNA
splicing
processes.
Molecular
docking
simulations
suggested
pore
complex
NDC1
dominated
process.
This
work
presents
kind
Ir(III)
metallohelices-based
agent
highest
PDT
efficacy,
highlights
importance
metallohelices'
chirality,
provides
inspirations
for
future
helical
metallodrugs.
Langmuir,
Год журнала:
2024,
Номер
40(23), С. 12226 - 12238
Опубликована: Май 30, 2024
We
have
red-shifted
the
light
absorbance
property
of
a
Re(I)-tricarbonyl
complex
via
distant
conjugation
ferrocene
moiety
and
developed
novel
ReFctp,
[Re(Fctp)(CO)3Cl],
where
Fctp
=
4′-ferrocenyl-2,2′:6′,2″-terpyridine.
ReFctp
showed
green
to
red
absorption
ability
blue
emission,
indicating
its
potential
for
photodynamic
therapy
(PDT)
application.
The
introduced
ferrocene-based
transitions,
which
lie
at
higher
wavelength
within
PDT
therapeutic
window.
time-dependent
density
functional
theory
excited
state
calculations
revealed
an
efficient
intersystem
crossing
is
helpful
PDT.
elicited
both
type
I
II
pathways
reactive
oxygen
species
(ROS)
generation
facilitated
NADH
(1,4-dihydro-nicotinamide
adenine
dinucleotide)
oxidation
upon
exposure
visible
light.
Importantly,
effective
penetration
through
layers
clinically
relevant
3D
multicellular
tumor
spheroids
localized
primarily
in
mitochondria
(Pearson's
correlation
coefficient,
PCC
0.65)
A549
cancer
cells.
produced
more
than
20
times
phototoxicity
(IC50
∼1.5
μM)
by
inducing
ROS
altering
mitochondrial
membrane
cells
nonferrocene
analogue
Retp,
[Re(CO)3(tp)Cl],
tp
2,2′:6′,2″-terpyridine.
induced
apoptotic
mode
cell
death
with
notable
photocytotoxicity
index
(PI,
PI
IC50dark/IC50light)
selectivity
(SI,
SI
normal
cell's
IC50dark/cancer
IC50light)
range
25–33.
Abstract
Despite
the
advent
of
various
medical
interventions
for
cancer
treatment,
disease
continues
to
pose
a
formidable
global
health
challenge,
necessitating
development
new
therapeutic
approaches
more
effective
treatment
outcomes.
Photodynamic
therapy
(PDT),
which
utilizes
light
activate
photosensitizer
produce
cytotoxic
reactive
oxygen
species
(ROS)
eradicating
cells,
has
emerged
as
promising
approach
due
its
high
spatiotemporal
precision
and
minimal
invasiveness.
However,
widespread
clinical
use
PDT
faces
several
challenges,
including
inefficient
production
ROS
in
hypoxic
tumor
microenvironment,
limited
penetration
depth
biological
tissues,
inadequate
accumulation
photosensitizers
at
site.
Over
past
decade,
there
been
increasing
interest
utilization
photofunctional
transition
metal
complexes
applications
their
intriguing
photophysical
photochemical
properties.
This
review
provides
an
overview
current
design
strategies
used
innovative
phototherapeutics,
aiming
address
limitations
associated
with
achieve
The
challenges
future
perspectives
on
translation
are
also
discussed.